论文部分内容阅读
目的评价单穿刺点经胸微创封堵治疗房间隔缺损(ASD)合并室间隔缺损(VSD)的安全性及有效性。方法纳入2014年6月至2015年8月于我院成功完成单穿刺点经胸微创封堵术治疗ASD合并VSD的8例患儿,分析患儿在术后第l个月、3个月、6个月的门诊随访资料。观察围术期及随访期间患者残余分流、瓣膜反流、心律失常等并发症发生情况。结果 8例患儿中,术后早期均无残余分流、心律失常,微量三尖瓣反流(TR)患者1例(12.5%)。平均随访时间5~9(6±2)个月,各瓣膜均未发现中度及以上反流,未发现存在血栓、严重心律失常、死亡的患者。结论单穿刺点经胸微创封堵治疗ASD合并VSD安全、有效,且更为微创。
Objective To evaluate the safety and efficacy of transcatheter closure of ventricular septal defect (ASD) combined with ventricular septal defect (VSD) with minimally invasive percutaneous puncture. Methods Eight children with ASD combined with VSD who underwent single puncture and transcatheter minimally invasive sealing in our hospital from June 2014 to August 2015 were enrolled in this study. , 6 months outpatient follow-up information. During the perioperative period and follow-up period, residual shunt, valvular regurgitation and arrhythmia were observed. Results There were no residual shunt, arrhythmia and trace tricuspid regurgitation (TR) in 1 patient (12.5%) in 8 cases. The average follow-up time ranged from 5 to 9 (6 ± 2) months. None of the valvular valves had any moderate or severe reflux and no thrombosis, severe arrhythmia, or death were found. Conclusion Single puncture point transcatheter minimally invasive sealing ASD combined with VSD safe, effective, and more minimally invasive.